Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Faron BEXMAB Phase II study results

By Inderes
Faron Pharmaceuticals

Faron will be hosting a virtual webinar to discuss the full analysis of r/r MDS as well as new frontline HR MDS patient data on Monday, 2 June 2025.

Stay up to date
Investor events

Recent videos

Intellego Technologies, Audiocast, Q4'25
20.02.2026, 15.00 Intellego Technologies
Cantargia, Audiocast, Q4'25
20.02.2026, 15.00 Cantargia
Nepa, Audiocast, Q4'25
20.02.2026, 11.00 Nepa
HCA Morgenbørs 20/02 - Fokus på regnskabsaktuelle ALK, samt Novo
20.02.2026, 10.18 ALK-Abelló
Pierce Group, Audiocast, Q4'25
20.02.2026, 10.00 Pierce Group
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.